Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

SIOG 2016 /
Utilisation of older and newer agents in treating mantle cell lymphoma

17th - 19th Nov 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.11.16
Views: 1657

Prof Pierre Soubeyran - University of Bordeaux, Bordeaux, France

Prof Soubeyran speaks with ecancertv at SIOG 2016 about optimal treatment of elderly patients with mantle cell lymphoma.

He describes how treating a disease which mostly occurs in the geriatric setting raises additional considerations, such as an emphasis on patient autonomy during and after treatment.

Prof Soubeyran also considers the role of SIOG and young researchers in supporting mutual development and peer learning.

This service has been kindly supported by an unrestricted grant from Merck/MSD.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation